Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
AstraZeneca
Takeda
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
NGM Biopharmaceuticals, Inc
Aprea Therapeutics
Hutchmed
Black Diamond Therapeutics, Inc.
Kymab Limited
Alliance for Clinical Trials in Oncology
Stanford University
BeiGene
Rain Oncology Inc
Pfizer
ADC Therapeutics S.A.
Cancer Research and Biostatistics Clinical Trials Consortium
Massachusetts General Hospital
pharmaand GmbH
Genmab
Nektar Therapeutics
Incyte Corporation
OBI Pharma, Inc
Incyte Corporation
Silverback Therapeutics
Pfizer
Incyte Corporation
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Incyte Corporation
University of Chicago
Icahn School of Medicine at Mount Sinai
Eli Lilly and Company
Stanford University
Butler Hospital
University of Kansas Medical Center
Beth Israel Deaconess Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
Roswell Park Cancer Institute
Fox Chase Cancer Center
Curis, Inc.
INSYS Therapeutics Inc
Altor BioScience
Massachusetts General Hospital